Sampre Nutritions Ltd - Stock Valuation and Financial Performance

BSE: 530617 | NSE: | Consumer Food | Small Cap

Sampre Nutritions Share Price

77.15 -0.96 -1.23%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Sampre Nutritions

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Sampre Nutritions stock performance -

mw4me loader
P/E Ratio (SA):
104.00
Market Cap:
140.3 Cr.
52-wk low:
50.2
52-wk high:
101.2

Is Sampre Nutritions Ltd an attractive stock to invest in?

1. Is Sampre Nutritions Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sampre Nutritions Ltd is a below average quality company.

2. Is Sampre Nutritions Ltd undervalued or overvalued?

The key valuation ratios of Sampre Nutritions Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Sampre Nutritions Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sampre Nutritions Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Sampre Nutritions:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sampre Nutritions Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 7.6%6.1%11.1%8.8%7.1%8.7%8.5%5.3%6.7%6.6%-
Value Creation
Index
-0.5-0.6-0.2-0.4-0.5-0.4-0.4-0.6-0.5-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 15.310.145.133.632.728.724.918.223.137.122
Sales YoY Gr.--34.1%346.9%-25.5%-2.8%-12.2%-13.4%-26.6%26.9%60.4%-
Adj EPS 0.70.51.90.90.50.50.70.20.70.50.8
YoY Gr.--32.9%293.6%-49.2%-46.8%0%42%-77.5%318.8%-23.9%-
BVPS (₹) 17.517.819.620.420.921.522.222.42327.446.1
Adj Net
Profit
0.30.20.90.50.20.20.30.10.30.41
Cash Flow from Ops. 0.1-0.31.2-11.55.72.6-0.22.40.9-
Debt/CF from Ops. 39.3-11.46.6-12.69.43.57.8-119.88.819.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 10.3%2.6%14.3%60.4%
Adj EPS -3.5%0.4%-10.4%-23.9%
BVPS5.1%5.6%7.2%19%
Share Price 22.5% 42.8% 46.3% 3.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
4.12.79.94.72.42.43.20.732.22
Op. Profit
Mgn %
11.918.36.28.99.313.115.718.815.210.924
Net Profit
Mgn %
2.22.221.40.70.91.40.41.40.96.1
Debt to
Equity
0.20.50.81.31.41.91.921.90.9-
Working Cap
Days
9920571119128160192277241168137
Cash Conv.
Cycle
3411733567773621251309337

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 2.00%

Sales growth is growing at healthy rate in last 3 years 14.30%

Debt to equity has declined versus last 3 years average to 0.89

Net Profit has been subdued in last 3 years -10.44%

Sales growth is not so good in last 4 quarters at -37.10%

Latest Financials - Sampre Nutritions Ltd.

Standalone Consolidated
TTM EPS (₹) 0.8 -
TTM Sales (₹ Cr.) 22.2 -
BVPS (₹.) 46.1 -
Reserves (₹ Cr.) 65 -
P/BV 1.70 -
PE 104.00 -
From the Market
52 Week Low / High (₹) 50.15 / 101.17
All Time Low / High (₹) 1.05 / 296.35
Market Cap (₹ Cr.) 140
Equity (₹ Cr.) 18
Face Value (₹) 10
Industry PE 64.4

Management X-Ray of Sampre Nutritions:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Sampre Nutritions

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales15104534332925182337
Operating Expenses 1484231302521152033
Manufacturing Costs85107741081014
Material Costs413021201884715
Employee Cost 0000111111
Other Costs 2122222223
Operating Profit 2233344334
Operating Profit Margin (%) 11.9%16.9%6.1%8.9%9.3%13.0%15.7%18.8%15.1%10.9%
Other Income 0000000000
Interest 0011122222
Depreciation 1111111222
Exceptional Items 0000000000
Profit Before Tax 0011000000
Tax 0000000000
Profit After Tax 0010000000
PAT Margin (%) 2.2%1.3%1.9%1.3%0.7%0.8%1.4%0.4%1.3%0.9%
Adjusted EPS (₹)0.70.31.80.90.50.50.70.20.60.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 89910101011111119
Share Capital 5555555557
Reserves 44555666612
Minority Interest0000000000
Debt23713131819212115
Long Term Debt024791111121311
Short Term Debt2246478885
Trade Payables1142265544
Others Liabilities 4331233226
Total Liabilities 15172426273837383844

Fixed Assets

Gross Block21222223293337344040
Accumulated Depreciation11121314161719161719
Net Fixed Assets101099131519182221
CWIP 0046295504
Investments 0000000000
Inventories0124567777
Trade Receivables3465554667
Cash Equivalents 0000001000
Others Assets1223232224
Total Assets 15172426273837383844

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 001-1163021
PBT 0011000000
Adjustment 2222232334
Changes in Working Capital -2-2-1-4-13-0-3-1-3
Tax Paid 0000000000
Cash Flow From Investing Activity -3-1-4-3-2-10-1-1-1-4
Capex -3-1-4-3-2-10-1-1-1-4
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 313405-10-23
Net Proceeds from Shares 00000000010
Net Proceeds from Borrowing 012333-111-2
Interest Paid 00-1-10-1-1-1-2-2
Dividend Paid 0000000000
Others 3022-2310-1-2
Net Cash Flow 0000001-100
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)4.141.529.534.692.432.273.190.72.812.32
ROCE (%)7.576.0911.148.797.068.718.455.266.656.56
Asset Turnover Ratio1.120.652.231.341.220.880.660.480.610.91
PAT to CFO Conversion(x)N/AN/A1N/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days651283959526163989666
Inventory Days426163348699514311470
Payable Days1242263152347724247624092

Sampre Nutritions Ltd Stock News

Sampre Nutritions Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Sampre Nutritions on 21-Nov-2024 16:59 is ₹77.15.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Sampre Nutritions stood at ₹140.3.
The latest P/E ratio of Sampre Nutritions as of 21-Nov-2024 16:59 is 104.0.
The latest P/B ratio of Sampre Nutritions as of 21-Nov-2024 16:59 is 1.70.
The 52-week high of Sampre Nutritions is ₹101.2 and the 52-week low is ₹50.15.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sampre Nutritions is ₹22.23 ( Cr.) .

About Sampre Nutritions Ltd

Sampre Nutritions was incorporated on December 3, 1991 as a Public company.  Lately it was converted into a public limited company in 16 May 1994.  The company is engaged in the manufacture and sale of sugar-boiled candies and toffees.

The multi-locational facilities of the Group are equipped with APV Baker 4 bank Deposited Line, New generation imported Uni plast lines cut & wrap lines, Cooling equipment and Packing machines. Continuous investments in the latest technology for each of the product lines have ensured the highest global standards. Supporting quality and optimum productivity across the integrated network are world-class laboratories and a strong R&D. The R&D also provides a one-stop source for everything from development to delivery of products to exacting international standards.

The company’s registered office is located at Kiran Arcade, 3 Floor, 100 Sarojini Devi Road Secunderabad,Andhra Pradesh-500003 .

Clientele

  • PROCTER & GAMBLE INDIA LTD  
  • WARNER LAMBERT INDIA LTD
  • CADBURY INDIA LIMITED 
  • INDIAN AIRLINES LTD 
  • RANBAXY LABORATORIES LTD 
  • KNOLL PHARMACEUTICALS LTD (BOOTS) 
  • CIPLA LIMITED
  • DABUR INDIA LIMITED
  • AMRUTANJAN LIMITED
  • AUROBINDO PHARMA LIMITED
  • ANCHOR HEALTH & BEAUTY CARE PVT LTD
  • Dr. MOREPEN LABORATORIES LTD
  • HIMALAYA DRUG COMPANY
  • BAIDYANATH AYURVED BHAVAN PVT LTD
  • ELDER PHARMACEUTICALS LTD
  • MICRONUTRIENT, CANADA
  • ITC LIMITED

Awards and Achievements

The quality initiatives have credited the Group with many coveted citations viz., Pinnacle Awards by P&G, USA for Outstanding Quality Assurance Standards for 2 consecutive years, and the Golden Peacock National Quality Award in 1998 for Outstanding Quality Efforts in Small Sector Manufacturing.

The Rajiv Gandhi National Quality Award given by the Govt. of India and an ISO 9002 certification was topped by Sampre becoming the first confectionery Company in South East Asia to receive HACCP certification - the highest quality certification from BVQI –Netherlands for the Food industry.


  •  
  • Read More Read Less
    You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
    © 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.